B12 Slows Functional Decline in Early-stage ALS, Data Show Written by | Treatment with ultrahigh-dose methylcobalamin the physiologically active form of vitamin B12 effectively slowed functional decline in people with early-stage amyotrophic lateral sclerosis (ALS) and moderate progression, data from a small Phase 3 trial in Japan show
Bacteriostatic water itself causes very few side effects
Importantly, animals were singly housed to eliminate the exchange and cross-contamination of intestinal microbiomes, a factor that potentially biases studies with group-housed animals by minimizing microbiome variations for co-housed animals within a cohort
Researchers can explore additional educational resources through the Frontier Peptide Research Library, which features articles covering peptide biology, molecular signaling, laboratory methodologies, analytical chemistry, peptide handling, and current peptide research topics
Yes for laboratory research purposes
How Often to Dose The following instructions are suitable for the home-treatment of acute (short-lived) problems rather than chronic conditions